Investing in the Future
of Healthcare
DaVita Venture Group invests in, acquires, and co-develops solutions that improve clinical outcomes and patient experiences. Our goal is to transform kidney care through strategic innovation.
Our Investment Priorities
Care Models
Tech-enabled services, home treatments and value-based care
Digital Health
Data and artificial intelligence to improve care delivery
New Service Lines
Extend DaVita’s clinical excellence to adjacent verticals of care
Life Sciences
Devices and diagnostics improving outcomes and reducing costs
Our investments slow kidney disease progression, support poly-chronic disease management, and accelerate innovation from initial diagnosis to transplant
All capital comes from DaVita. We take an active strategic role to contribute clinical and operational expertise, product development resources, data insights and more.
Venture Capital:
Invest up to $10M in Series A and beyond
Corporate Development:
Execute scale investments and joint ventures
Partnerships:
Co-develop, pilot, and integrate care models & technologies
Portfolio
All capital comes from DaVita. We typically invest at Series A and beyond with check sizes that range from $1M-10M. We often syndicate but take an active role in all of our investments through Board observerships or director roles. Our support for portfolio companies extends beyond the board room with clinical and value-based care delivery expertise, as well as business development, hiring, and technical support.
Meet Our Team
Contact Us
Interested in working with DaVita Venture Group? Reach out to our team directly.